AstraZeneca Plc

by Mike Memoli The top pharmaceutical group has named John Castellani, most recently president of the Business Roundtable, as it's new president and CEO, effective September 1. He replaces Billy Tauzin, the former Louisiana Congressman who held one of...

In this week’s coverage of the trial of Michael Jackson’s personal physician, Dr. Conrad Murray, articles have been consistent in describing the drug that killed the pop star: Tuesday: “the dangerous surgical anesthetic propofol”...

Germany's leader is feted at the Obamas' fourth White House State Dinner. With full guest list....

California Atty. Gen. Kamala D. Harris on Thursday announced a $68.5-million multistate settlement with AstraZeneca Pharmaceuticals after the states sued the company for allegedly using unfair and deceptive marketing practices for its antipsychotic drug...

The U.S. Attorney’s Office for the Eastern District of Pennsylvania announced Thursday that it has collected nearly $4.4 billion in civil penalties since 2004. While the rules for disbursing those payments between state and federal agencies make it...

A Food and Drug Administration advisory panel recommended today that drug-maker AstraZeneca be allowed to expand the labeling on its cholesterol-lowering drug Crestor to include some people who do not have high cholesterol levels. That could allow as many...

Dow Jones Newswires | The U.S. Justice Department on Tuesday confirmed a settlement under which AstraZeneca PLC will pay about $520 million to resolve allegations the company improperly promoted the antipsychotic Seroquel. A settlement has been expected.....

LONDON (Reuters) - The dollar edged higher, gold steadied and European shares remained near five-year highs on Tuesday as investors wait to see if the U.S. Federal Reserve will give any signal on the future of its stimulus program. The dollar was up 0....

* Drugmaker eyes Cambridge Biomedical Campus - sources * Relocation centrepiece of new CEO's restructuring plan * New research centre and corporate HQ to cost some $500 mln By Ben Hirschler and Tom Bill LONDON, May 20 (Reuters) - AstraZeneca is...

MONTERREY, 20 mayo (Reuters) - La farmacéutica mexicana Genomma Lab dijo el lunes que firmó un contrato de licencia para el uso de la marca de medicamentos de libre venta Losec, que le permitirá distribuir el popular antiácido por 99 años. Genomma...

LONDON (Reuters) - AstraZeneca has enrolled the first patient into a final-stage clinical trial of a new drug for a rare type of leukemia as the group's new CEO delivers on a promise to accelerate its oncology programs. Britain's second-biggest drugmaker...

By Jessica Toonkel NEW YORK, May 15 (Reuters) - Before Optimer Pharmaceuticals Inc even put itself up for sale earlier this year, Cubist Pharmaceuticals Inc offered to buy the antibiotic maker for $20 per share, or nearly $1 billion, two people...